Press releases

December 23, 2020

Press release - Regulatory

Targovax ASA issues options to employees

December 15, 2020

Press release - Non-regulatory

Targovax ASA: Save the date – Capital Markets Day 2021

December 14, 2020

Press release - Regulatory

Targovax ASA: Registration of share capital increase following exercise of options

December 10, 2020

Press release - Non-regulatory

Targovax to present at DNB’s 11[th] Annual Nordic Healthcare Conference

December 8, 2020

Press release - Regulatory

Targovax ASA: Exercise of options and resolution to increase the share capital

December 3, 2020

Press release - Regulatory

Targovax ASA: Primary insider share purchase

December 2, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to online presentation at 10:00 CET 2 December

December 1, 2020

Press release - Non-regulatory

Targovax announces impressive objective responses as well as effects on non-injected lesions in ONCOS-102 trial in anti-PD1 refractory melanoma patients

November 24, 2020

Press release - Non-regulatory

Targovax demonstrates encouraging survival data for ONCOS-102 in mesothelioma

November 17, 2020

Press release - Non-regulatory

Targovax to present at Bryan Garnier & Co Virtual European Healthcare Conference

November 9, 2020

Press release - Non-regulatory

Targovax announces poster at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 5, 2020

Press release - Non-regulatory

Targovax ASA: third quarter 2020 results

November 2, 2020

Press release - Non-regulatory

Targovax to present at the World Immunotherapy Congress

October 28, 2020

Press release - Non-regulatory

Targovax announces formation of new Scientific Advisory Board

October 26, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s third quarter 2020 results, Thursday 5 November

October 22, 2020

Press release - Regulatory

TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

October 20, 2020

Press release - Regulatory

TARGOVAX ASA – NO SUBSEQUENT OFFERING

October 19, 2020

Press release - Regulatory

TARGOVAX ASA – APPROVAL AND PUBLICATION OF PROSPECTUS

October 19, 2020

Press release - Non-regulatory

Targovax announces accepted abstract at SITC

October 14, 2020

Press release - Regulatory

TARGOVAX ASA – NOTIFICATION OF SHAREHOLDING

October 14, 2020

Press release - Regulatory

TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

October 14, 2020

Press release - Regulatory

TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

October 14, 2020

Press release - Regulatory

TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

October 13, 2020

Press release - Non-regulatory

Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer

October 12, 2020

Press release - Non-regulatory

Targovax granted European Patent for ONCOS-102 in combination with checkpoint inhibitors

September 18, 2020

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of restricted stock units

September 14, 2020

Press release - Non-regulatory

Targovax is invited to present at H.C. Wainwright 22[nd] Annual Global Investment Conference

September 2, 2020

Press release - Non-regulatory

Targovax is invited to present at Pareto Nordic Healthcare conference and RAS-targeted drug development summit

August 31, 2020

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units by primary insider and resolution to increase the share capital

August 20, 2020

Press release - Regulatory

Targovax ASA: second quarter and first half 2020 results

August 12, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2020 results, Thursday 20 August

June 29, 2020

Press release - Non-regulatory

Targovax and Oblique enter collaboration to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms

June 24, 2020

Press release - Non-regulatory

Targovax announces presentation of pre-clinical data from Next Generation ONCOS at AACR Virtual Annual Conference

June 23, 2020

Press release - Non-regulatory

Targovax announces collaboration to evaluate ONCOS-102 in combination with KEYTRUDA® in mesothelioma

June 22, 2020

Press release - Non-regulatory

Targovax to present at the upcoming 2020 Virtual European Biotech Investor Day 2020

June 22, 2020

Press release - Non-regulatory

Targovax’s ONCOS-102 mesothelioma 12-month data powerfully demonstrate broad immune activation linked to clinical benefit

June 4, 2020

Press release - Non-regulatory

Targovax enters collaboration with Leidos to add checkpoint inhibitor functionality to ONCOS viruses

May 14, 2020

Press release - Non-regulatory

Targovax announces that the ONCOS-102 and durvalumab abstract is selected for a Poster Discussion Session at ASCO

May 7, 2020

Press release - Regulatory

Targovax ASA: First quarter 2020 results

May 6, 2020

Press release - Non-regulatory

Targovax announces that abstract on interim phase I clinical data from the phase I/II peritoneal trial is accepted at ASCO

May 5, 2020

Press release - Regulatory

Targovax ASA issues options to new member of management

May 4, 2020

Press release - Non-regulatory

Targovax releases update for mesothelioma trial combining ONCOS-102 and chemotherapy

April 30, 2020

Press release - Non-regulatory

Targovax ASA appoints Dr Victor Levitsky as Chief Scientific Officer

April 30, 2020

Press release - Regulatory

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

April 29, 2020

Press release - Non-regulatory

Targovax ASA: Minutes from the Annual General Meeting

April 29, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to online presentation of Targovax’s first quarter 2020 results, Thursday 7 May

April 22, 2020

Press release - Non-regulatory

Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology

April 3, 2020

Press release - Non-regulatory

Targovax ASA announces proposed new Chairman of the Board

April 2, 2020

Press release - Non-regulatory

Notice of Annual General Meeting

March 30, 2020

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of restricted stock units

March 26, 2020

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

March 26, 2020

Press release - Non-regulatory

Targovax to present at the 2020 Solebury Trout Virtual Investor Conference today

March 23, 2020

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insiders in connection with settlement of RSUs

March 20, 2020

Press release - Non-regulatory

Impact of corona virus (COVID-19) on Targovax’s operations

March 11, 2020

Press release - Regulatory

Targovax ASA: Fourth quarter 2019 results

March 11, 2020

Press release - Regulatory

Targovax ASA: Annual Report 2019

March 3, 2020

Press release - Non-regulatory

Targovax announces completed enrollment in the ONCOS-102 trial in anti-PD1 refractory melanoma

March 3, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2019 results, Wednesday 11 March

January 31, 2020

Press release - Regulatory

TARGOVAX ASA – NO SUBSEQUENT OFFERING

January 28, 2020

Press release - Regulatory

TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

January 22, 2020

Press release - Regulatory

TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

January 22, 2020

Press release - Regulatory

TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

January 22, 2020

Press release - Regulatory

TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

January 22, 2020

Press release - Non-regulatory

Reminder: Targovax ASA – Invitation to investor call

January 21, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to investor call

January 21, 2020

Press release - Non-regulatory

Targovax announces encouraging data in mesothelioma study combining ONCOS-102 and standard of care chemotherapy

January 8, 2020

Press release - Non-regulatory